Evaluation and management of abnormal liver chemistry tests in the asymptomatic outpatient

Laurel H. Hartwell, Jonathan M. Schwartz

Research output: Contribution to journalArticle

Abstract

• Objective: To review the evaluation and management of liver enzyme abnormalities in asymptomatic patients. • Methods: Review of the literature. • Results: Liver chemistry tests include alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase, bilirubin, and gammaglutamyltransferase (GGT). In general, AST and ALT abnormalities suggest a pattern of hepatocellular injury or necrosis, whereas alkaline phosphatase, bilirubin, and GGT elevations reflect cholestatic injury. A detailed history with attention paid to alcohol consumption, medication and herb or supplement use, travel history, and risk factors for viral hepatitis and metabolic syndrome can often quickly narrow the differential diagnosis. Nonalcoholic fatty liver disease is an increasing cause of chronic liver disease and should be approached in the context of the metabolic syndrome. • Conclusion: A thorough understanding of the pathogenesis of abnormal liver chemistry tests, prevalence and risk factors of common liver diseases, and a clinically directed, stepwise approach to evaluation can help to avoid common pitfalls.

Original languageEnglish (US)
Pages (from-to)525-534
Number of pages10
JournalJournal of Clinical Outcomes Management
Volume16
Issue number11
StatePublished - Nov 2009
Externally publishedYes

Fingerprint

Outpatients
gamma-Glutamyltransferase
Aspartate Aminotransferases
Alanine Transaminase
Bilirubin
Alkaline Phosphatase
Liver Diseases
Liver
Wounds and Injuries
Alcohol Drinking
Hepatitis
Differential Diagnosis
Chronic Disease
Necrosis
History
Enzymes
Non-alcoholic Fatty Liver Disease

ASJC Scopus subject areas

  • Medicine(all)
  • Health Policy

Cite this

Evaluation and management of abnormal liver chemistry tests in the asymptomatic outpatient. / Hartwell, Laurel H.; Schwartz, Jonathan M.

In: Journal of Clinical Outcomes Management, Vol. 16, No. 11, 11.2009, p. 525-534.

Research output: Contribution to journalArticle

@article{79f8f4a0ee7e4e2bb2a1c6b2dc3e343d,
title = "Evaluation and management of abnormal liver chemistry tests in the asymptomatic outpatient",
abstract = "• Objective: To review the evaluation and management of liver enzyme abnormalities in asymptomatic patients. • Methods: Review of the literature. • Results: Liver chemistry tests include alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase, bilirubin, and gammaglutamyltransferase (GGT). In general, AST and ALT abnormalities suggest a pattern of hepatocellular injury or necrosis, whereas alkaline phosphatase, bilirubin, and GGT elevations reflect cholestatic injury. A detailed history with attention paid to alcohol consumption, medication and herb or supplement use, travel history, and risk factors for viral hepatitis and metabolic syndrome can often quickly narrow the differential diagnosis. Nonalcoholic fatty liver disease is an increasing cause of chronic liver disease and should be approached in the context of the metabolic syndrome. • Conclusion: A thorough understanding of the pathogenesis of abnormal liver chemistry tests, prevalence and risk factors of common liver diseases, and a clinically directed, stepwise approach to evaluation can help to avoid common pitfalls.",
author = "Hartwell, {Laurel H.} and Schwartz, {Jonathan M.}",
year = "2009",
month = "11",
language = "English (US)",
volume = "16",
pages = "525--534",
journal = "Journal of Clinical Outcomes Management",
issn = "1079-6533",
publisher = "Turner White Communications Inc.",
number = "11",

}

TY - JOUR

T1 - Evaluation and management of abnormal liver chemistry tests in the asymptomatic outpatient

AU - Hartwell, Laurel H.

AU - Schwartz, Jonathan M.

PY - 2009/11

Y1 - 2009/11

N2 - • Objective: To review the evaluation and management of liver enzyme abnormalities in asymptomatic patients. • Methods: Review of the literature. • Results: Liver chemistry tests include alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase, bilirubin, and gammaglutamyltransferase (GGT). In general, AST and ALT abnormalities suggest a pattern of hepatocellular injury or necrosis, whereas alkaline phosphatase, bilirubin, and GGT elevations reflect cholestatic injury. A detailed history with attention paid to alcohol consumption, medication and herb or supplement use, travel history, and risk factors for viral hepatitis and metabolic syndrome can often quickly narrow the differential diagnosis. Nonalcoholic fatty liver disease is an increasing cause of chronic liver disease and should be approached in the context of the metabolic syndrome. • Conclusion: A thorough understanding of the pathogenesis of abnormal liver chemistry tests, prevalence and risk factors of common liver diseases, and a clinically directed, stepwise approach to evaluation can help to avoid common pitfalls.

AB - • Objective: To review the evaluation and management of liver enzyme abnormalities in asymptomatic patients. • Methods: Review of the literature. • Results: Liver chemistry tests include alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase, bilirubin, and gammaglutamyltransferase (GGT). In general, AST and ALT abnormalities suggest a pattern of hepatocellular injury or necrosis, whereas alkaline phosphatase, bilirubin, and GGT elevations reflect cholestatic injury. A detailed history with attention paid to alcohol consumption, medication and herb or supplement use, travel history, and risk factors for viral hepatitis and metabolic syndrome can often quickly narrow the differential diagnosis. Nonalcoholic fatty liver disease is an increasing cause of chronic liver disease and should be approached in the context of the metabolic syndrome. • Conclusion: A thorough understanding of the pathogenesis of abnormal liver chemistry tests, prevalence and risk factors of common liver diseases, and a clinically directed, stepwise approach to evaluation can help to avoid common pitfalls.

UR - http://www.scopus.com/inward/record.url?scp=73949151564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73949151564&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:73949151564

VL - 16

SP - 525

EP - 534

JO - Journal of Clinical Outcomes Management

JF - Journal of Clinical Outcomes Management

SN - 1079-6533

IS - 11

ER -